Carbone, Carmine, Geny Piro, Anna Tamburrino, MinaMaria Mihaela, Silvia Zanini, Giampaolo Tortora, and Davide Melisi. 2013. “TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance”. JOP. Journal of the Pancreas 14 (5S), 562. https://doi.org/10.6092/1590-8577/1866.